Cargando…
Questioning flecainide's mechanism of action in the treatment of catecholaminergic polymorphic ventricular tachycardia
Autores principales: | Williams, Alan J., Bannister, Mark L., Thomas, N. Lowri, Sikkel, Markus B., Mukherjee, Saptarshi, Maxwell, Chloe, MacLeod, Kenneth T., George, Christopher H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5088245/ https://www.ncbi.nlm.nih.gov/pubmed/27800620 http://dx.doi.org/10.1113/JP272497 |
Ejemplares similares
-
The Antiarrhythmic Mechanisms of Flecainide in Catecholaminergic Polymorphic Ventricular Tachycardia
por: Li, Yukun, et al.
Publicado: (2022) -
Insights on the mechanism of flecainide in catecholaminergic polymorphic ventricular tachycardia
por: Davidson, Ross, et al.
Publicado: (2023) -
Efficacy of Flecainide in Catecholaminergic Polymorphic Ventricular Tachycardia Is Mutation-Independent but Reduced by Calcium Overload
por: Hwang, Hyun Seok, et al.
Publicado: (2019) -
Antiarrhythmic Effects of Carvedilol and Flecainide in Cardiomyocytes Derived from Catecholaminergic Polymorphic Ventricular Tachycardia Patients
por: Pölönen, R. P., et al.
Publicado: (2018) -
Safety and efficacy of flecainide for patients with catecholaminergic polymorphic ventricular tachycardia: A systematic review and meta-analysis
por: Wang, Guangqiang, et al.
Publicado: (2019)